Regulation of psychostimulant‐induced signaling and gene expression in the striatum
Open Access
- 21 January 2008
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 104 (6) , 1440-1449
- https://doi.org/10.1111/j.1471-4159.2008.05240.x
Abstract
J. Neurochem. (2008) 104, 1440–1449. Abstract Amphetamine (AMPH) and cocaine are indirect dopamine agonists that activate multiple signaling cascades in the striatum. Each cascade has a different subcellular location and duration of action that depend on the strength of the drug stimulus. In addition to activating D1 dopamine‐Gs‐coupled‐protein kinase A signaling, acute psychostimulant administration activates extracellular‐regulated kinase transiently in striatal cells; conversely, inhibition of extracellular‐regulated kinase phosphorylation decreases the ability of psychostimulants to elevate locomotor behavior and opioid peptide gene expression. Moreover, a drug challenge in rats with a drug history augments and prolongs striatal extracellular‐regulated kinase phosphorylation, possibly contributing to behavioral sensitization. In contrast, AMPH activates phosphoinositide‐3 kinase substrates, like protein kinase B/Akt, only in the nuclei of striatal cells but this transient increase induced by AMPH is followed by a delayed decrease in protein kinase B/Akt phosphorylation whether or not the rats have a drug history, suggesting that the phosphoinositide‐3 kinase pathway is not essential for AMPH‐induced behavioral sensitization. Chronic AMPH or cocaine also alters the regulation of inhibitory G protein‐coupled receptors in the striatum, as evident by a prolonged decrease in the level of regulator of G protein signaling 4 after non‐contingent or contingent (self‐administered) drug exposure. This decrease is exacerbated in behaviorally sensitized rats and reversed by re‐exposure to a cocaine‐paired environment. A decrease in regulator of G protein signaling 4 levels may weaken its interactions with metabotropic glutamate receptor 5, Gαq, and phospholipase C β that may enhance drug‐induced signaling. Alteration of these protein–protein interactions suggests that the striatum responds to psychostimulants with a complex molecular repertoire that both modulates psychomotor effects and leads to long‐term neuroadaptations.Keywords
This publication has 93 references indexed in Scilit:
- Drug-induced Alterations in the Extracellular Signal-regulated Kinase (ERK) Signalling Pathway: Implications for Reinforcement and ReinstatementCellular and Molecular Neurobiology, 2007
- Multiple Translational Isoforms Give Functional Specificity to Serum- and Glucocorticoid-induced Kinase 1Molecular Biology of the Cell, 2007
- Knockout of ERK1 Enhances Cocaine-Evoked Immediate Early Gene Expression and Behavioral PlasticityNeuropsychopharmacology, 2006
- N-terminally Truncated Variant of the Mouse GAIP/RGS19 Lacks Selectivity of Full-length GAIP/RGS19 Protein in Regulating ORL1 Receptor SignalingJournal of Molecular Biology, 2005
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Akt1 contains a functional leucine-rich nuclear export sequenceBiochemical and Biophysical Research Communications, 2005
- Serum/glucocorticoid‐inducible kinase can phosphorylate the cyclic AMP response element binding protein, CREBFEBS Letters, 2005
- Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functionsJournal of Neurochemistry, 2003
- Regulators of G-Protein signalling as new central nervous system drug targetsNature Reviews Drug Discovery, 2002
- Cell Cycle and Hormonal Control of Nuclear-Cytoplasmic Localization of the Serum- and Glucocorticoid-inducible Protein Kinase, Sgk, in Mammary Tumor CellsJournal of Biological Chemistry, 1999